نتایج جستجو برای: hemolytic anemia

تعداد نتایج: 66627  

Seyed Jalaledin Sharifi Tekiyeh,

Two cases of hemolytic anemia with spherocy­tosis were investigated. lnspite of chronic hemolysis tl::crc was no radiological changes in flat bones. Ma­nagement and entity of spherocytosis is discussed m detail in this paper. 

1993
Heui-Jung Pyo Young Joo Kwon Kyoung So Wee So Young Kwon Chang Hong Lee Suhnggwon Kim Jung Sang Lee Soo-Hun Cho Chul Whan Cha

During the four month period, from December 1988 to March 1989, there was an outbreak of Heinz body positive hemolytic anemia in 34 patients undergoing hemodialysis in a 500-bed hospital, Seoul, Korea. The episodes of hemolysis were not reduced by changing the charcoal column and reverse osmosis system, or by adding ascorbic acid to the dialysate. The concentrations of nitrate, copper, aluminum...

Journal: :Health Sciences 2023

We present a case report of 52-year-old male who de­veloped hemolytic anemia after undergoing mitral valve repair surgery. Hemolytic is rare complication repair, occurring in less than 1% pa­tients. Fragmentation the regurgitant jet leading cause intravascular In this particular case, was following anterior leaflet and hitting annulus. The pre­sence schistocytes echocardiographic evaluation hel...

2014
Ji Young Hong Ji Ye Jung Young Ae Kang Yoon Sung Bae Young Sam Kim Se Kyu Kim Joon Chang Moo Suk Park

Hemolytic uremic syndrome (HUS) is defined by the triad of mechanical intravascular hemolytic anemia with schistocytosis, thrombocytopenia and acute renal failure. Pulmonary involvement in HUS is known to be rare. We present the case of a 25-year-old male with diffuse alveolar hemorrhage and myocarditis followed by atypical hemolytic uremic syndrome. In this case, successful treatments included...

2014
Kathleen Abadie Kristen M Hege

INTRODUCTION Rituximab is an emerging treatment for autoimmune hemolytic anemia. We report the case of a patient with a five-year complete hematologic response to a third course of treatment with rituximab. Cases of response to rituximab re-treatments have been reported, but none to our knowledge that failed multiple prior treatments and achieved as durable a response. CASE PRESENTATION A 45-...

Journal: :American journal of hematology 2008
Kottayam Radhakrishnan Christopher Tan John Gallo

By MARY B. COOPER, B.A., M.T. (ASCP) I N 1909, Buchan and Comrie” reported the occurrence of erythrophagocytes in the peripheral blood of 2. newborn infants with ‘ ‘congenital anemia and enlargement of the spleen. ‘ ‘ In 193 I , Abt2 described these cells in blood smears of a case of anemia of the newborn. In 1938, Wyatt, Cooper and Groat9 reported 3 cases of the same disease in which the cells...

Farzaneh Moosavi Marzieh Nikparvar, Mohammad Reza Evazi, Tasnim Eftekhari

In patients with sickle cell disease, thrombotic microangiopathy is a rare complication. Also in sickle cell disease, intracardiac thrombus formation without structural heart diseases or atrial arrhythmias is a rare phenomenon. We herein describe a 22-year-old woman, who was a known case of sickle cell-βthalassemia, had a history of recent missed abortion, and was admitted with a vaso-occlusive...

2009
Tania Veuthey

Published in the Scandinavian Journal of Laboratory Animal Science an international journal of laboratory animal science Introduction In vertebrates, anemia is a common hematological disorder associated with several conditions such as drug toxicity, parasites, genetic or acquired defects, and blood loss (Criswell et al., 2000; Jollow & McMillan, 2001). The hemolytic activity of arylhydrazines, ...

2016

Introduction: Drug-induced immune hemolytic anemia (DIIHA) is known as an unpredictable and in some cases serious complication occurring upon pharmacotherapy. Cefazolin, as a first generation cephalosporin used against gram-negative bacteria, has rarely been reported to cause hemolytic anemia. Here, we report the first fatal case of hemolytic anemia associated with cefazolin treatment. Material...

Journal: :Laboratory medicine 2014
Avani A Pendse Claire H Edgerly Yuri Fedoriw

Hemolytic anemia can complicate the development of a variety of solid tumors and hematologic malignancies. Although patients may have an established diagnosis with documented metastases, microangiopathic hemolytic anemia (MAHA) can be a presenting feature of an occult malignancy. Prompt diagnosis is essential because conditions that mimic the symptoms of MAHA, including thrombotic thrombocytope...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید